Management of ulcers in lymphoedematous limbs

ABSTRACT

Lymphoedema is a progressive condition that can have a marked physical and psychological impact on affected patients and significantly reduce the quality of life. The ulcers on chronic lymphoedema patient, which often also makes it impossible for them to work. If left untreated, tends to progress or worsen. Ulcers in lymphoedema patients, therefore, represent not only a medical but also a psychological problem. The treatment is often regarded as being worse than it actually is. In our study of more than 25 years shows around 10% cases are due to chronic lymphodema. Ulcers of chronic lymphoedema are classified into four stages according to their presentation. Their management depends upon their stage of presentation. Patients with chronic lymphoedema and ulceration require a different approach to treatment. The specific issues associated with managing the patient with lymphoedematous ulceration include, limb shape distortion i.e., elephantiasis, care of the skin creases and folds, and swelling of the toes and fore foot. Stage I ulcers will heal with conservative treatment without any surgical intervention. Stage II ulcers needs debridement of the wound and split-thickness skin grafting. The most difficult to treat are the stage III and IV ulcers, due to associated skin changes and reduced vascularity. These cases need debulking along with excision of the ulcer. In order to prevent recurrence of the ulcer in all the four stages needs prolonged follow-up and limb care.

KEY WORDS

Lymphoedema - nodo-venous shunt - omentum - ulcer leg

• 1 Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, et al. Lymphoedema: An underestimated health problem. QJM 2003;96:731-8.
• 2 Moffatt CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulceration in a London population. QJM 2004;97:431-7.
• 3 Suma TK, Shenoy RK, Varghese J, Kuttikkal VV, Kumaraswami V. Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in lymphoedema caused by brugian filariasis. Southeast Asian J Trop Med Public Health 1997;28:826-30.
• 4 Vaqas B, Ryan TJ. Lymphoedema: Pathophysiology and management in resource-poor setting- relevance for lymphatic filariasis control programmes. Filaria J 2003;2:4.
• 5 Shenoy RK, Sandhya K, Suma TK, Kumaraswami V. A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Public Health 1995;26:301-5.
• 6 Tiwari A, Cheng, KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation and current treatment of lower limb lymphoedema. Arch Surg 2003;138:152-61.
• 7 Shenoy RK, Kumaraswami V, Suma TK, Rajan K, Radhakuttyamma G. A double blind placebo -controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 1999;93:367-77.
• 8 Wollina U, Hansel G, Krönert C, Heinig B. Using VAC to facilitate healing of traumatic wounds in patients with cronic lymphoedema. J Wound Care 2010;19:15-7.
• 9 McCann M. Toe bandaging for lymphoedema and venous ulceration. Br J Nurs 2008;17:428, 430-3.
• 10 Flecher A, Cullum N, Sheldon TA. A systematic review of compression treatment for venous leg ulcers. BMJ 1997;315:576-80.
• 11 Mortimer PS, Simmonds R, Rezvani M, Robbins M, Hopewell JW, Ryan TJ. The measurement of skin lymph flow by isotope clearance-reliability, reproducibility injection dynamics and effect of massage. J Invest Dermatol 1990;95:677-82.
• 12 Franks PJ, Moffatt CJ, Doherty DC, Williams AF, Jeffs E, Mortimer PS. Assessment of health-related quality of life in patients withlymphedema of the lower limb. Wound Repair Regen 2006;14:110-8.